Products

CBZ-D-Phenylglycinol

    • Product Name: CBZ-D-Phenylglycinol
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications
    HS Code 631984
    Product Name CBZ-D-Phenylglycinol
    Cas Number 14226-05-2
    Molecular Formula C16H17NO3
    Appearance White to off-white crystalline solid
    Melting Point 89-91 °C
    Boiling Point 450.6 °C (predicted)
    Flash Point 226.3 °C (predicted)
    Density 1.2 g/cm³ (predicted)
    Optical Rotation [α]D20 = -44.0° (c=1, CHCl3)
    Solubility Soluble in chloroform, methanol, and DMSO
    Smiles O=C(OCc1ccccc1)N[C@H](c1ccccc1)CO
    Inchi InChI=1S/C16H17NO3/c18-11-14(12-7-3-1-4-8-12)17-16(19)20-13-15-9-5-2-6-10-15/h1-10,14,18H,11,13H2,(H,17,19)/t14-/m1/s1

    As an accredited CBZ-D-Phenylglycinol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing CBZ-D-Phenylglycinol is supplied as a white crystalline solid in a sealed amber glass bottle, net quantity 5 grams, with desiccant.
    Container Loading (20′ FCL) CBZ-D-Phenylglycinol loaded in 20′ FCL: 25kg drums on pallets, securely braced, moisture-proof, dry, ventilated container.
    Shipping CBZ-D-Phenylglycinol is shipped at ambient temperature in a sealed, light-resistant container to protect its purity. Avoid moisture and extreme heat. Standard handling with proper labeling and SDS documentation applies. No special hazardous goods classification is required for routine courier transport.
    Storage Store CBZ-D-Phenylglycinol in a tightly sealed container in a cool, dry, well-ventilated area, protected from light and moisture. Keep away from strong oxidizers and incompatible materials. Avoid prolonged exposure to heat. Ensure the container is clearly labeled and closed when not in use to maintain stability and purity.
    Shelf Life Shelf life: typically 2 years when stored tightly sealed in a cool, dry, dark place, protected from moisture.
    Application of CBZ-D-Phenylglycinol

    In multi-step synthesis of chiral α-substituted carboxylic acid fragments for pharmaceutical intermediates, N-Cbz-D-Phenylglycinol is processed through an intramolecular alkoxide transfer to the carbamate carbonyl. The ring-closing step liberates benzyl alcohol and generates (R)-4-phenyl-2-oxazolidinone without requiring a separate carbonyl donor. In a 1000 L glass-lined reactor the charge ratio is maintained at 1.00 mol N-Cbz-D-Phenylglycinol to 1.05 mol sodium hydride (60% dispersion in mineral oil), with anhydrous tetrahydrofuran at 57 L/kg substrate and a substrate concentration of 1.01.2 M. The cyclization is run between 0 °C and 10 °C, with the addition time typically 24 h to avoid temperature overshoot above 15 °C; the reaction mass is aged at 20 °C until in-process HPLC shows starting material at or below 0.5% area. Quenching with methanol/water, extraction of benzyl alcohol, vacuum distillation of tetrahydrofuran, and recrystallization from MTBE/heptane yield the oxazolidinone. Downstream, the 4-phenyl-2-oxazolidinone is acylated with propionyl chloride at 1.2 mol per 1.0 mol of oxazolidinone, then enolized with lithium diisopropylamide at 1.05 mol per 1.0 mol of acylated auxiliary in tetrahydrofuran at −78 °C; subsequent alkylation with an electrophile at 1.52.0 mol produces the α-alkylated oxazolidinone intermediate. The terminal finished product type comprises enantiomerically enriched α-alkyl carboxylic acid synthons that enter registered API starting material programmes. Compliance boundary is set by ICH Q7 for active pharmaceutical ingredient intermediates, ICH Q11 for starting material designation, ICH Q3C for residual solvent control, and ICH Q3D for elemental impurities. Representative release criteria for the oxazolidinone intermediate are shown below.

    Release parameterAcceptance criterionAnalytical method / reference
    Chiral purity99.0% areaHPLC on chiral stationary phase, USP 621
    Total impurities1.0% areaHPLC, ICH Q3A
    Residual tetrahydrofuran720 ppmGas chromatography, ICH Q3C
    Residual methanol3000 ppmGas chromatography, ICH Q3C
    Residual benzyl alcohol0.5% w/wGas chromatography, internal release specification
    Elemental impuritiesPer ICH Q3DICP-MS, USP 233

    What Limits Residual Palladium After Catalytic Hydrogenolysis of CBZ-D-Phenylglycinol?

    Hydrogenolytic removal of the benzyloxycarbonyl group is used when the downstream process requires the free amino alcohol D-phenylglycinol. At production scale, a 2000 L stainless steel autoclave with a three-stage Rushton agitator is charged with N-Cbz-D-Phenylglycinol, methanol/tetrahydrofuran (1:1 v/v) at 610 L/kg, and water-wet 5% palladium on carbon (50% water) at 0.050.10 kg wet catalyst per kg substrate. Hydrogen is applied at 24 bar and 2540 °C for 38 h with agitation at 150250 rpm. Batch-to-batch variance in residual palladium is observed when the catalyst is charged as a dry powder rather than a water-wet paste, because poor wetting leads to local hydrogen depletion and increased palladium dissolution; the production procedure therefore specifies water-wet catalyst handling and a minimum solvent volume of 6 L/kg. After filtration through a 0.45 µm PTFE filter and carbon treatment, the filtrate is distilled at ≤45 °C and 100 mbar. The terminal finished product type is D-phenylglycinol free base, which is isolated as a low-melting solid or retained in solution for immediate ligand manufacture. Compliance includes ICH Q3D with palladium quantified by ICP-MS according to USP 233, residual solvent control per ICH Q3C, and site quality systems certified to ISO 9001:2015. The free base is hygroscopic and is stored under inert gas at 28 °C; exposure to moisture above 60% RH during sampling causes weight gain and lowers assay below accepted release limits.

    Following deprotection, D-phenylglycinol obtained from CBZ-D-Phenylglycinol is condensed with trimethyl borate and borane-dimethyl sulfide in anhydrous tetrahydrofuran to prepare oxazaborolidine-type chiral reduction ligands. In a dry 500 L glass-lined reactor, the feed ratio is 1.0 mol D-phenylglycinol to 1.05 mol trimethyl borate and 1.10 mol borane-dimethyl sulfide, with solvent at 810 L/kg; the reactor is pressurized with nitrogen and the jacket is held at 05 °C during controlled addition. The process generates dimethyl sulfide and methanol vapour, which are removed by vacuum distillation at 40 °C and 150 mbar; final catalyst solution is filtered through a 0.2 µm cartridge before loading into the reduction campaign. The terminal finished product type is a chiral oxazaborolidine catalyst used at 0.050.10 mol% for enantioselective ketone reduction to chiral secondary alcohols for pharmaceutical intermediates. Water content is monitored by Karl Fischer titration according to USP 921 and is maintained below 200 ppm because water quenches borane species and reduces batch yield. Compliance includes ICH Q3C for residual dimethyl sulfide and methanol, ISO 9001:2015 for process control, and ICH Q3D for palladium carryover from the preceding hydrogenolysis where the resulting alcohol enters a drug substance. Published catalytic turnover data for this specific N-Cbz-D-Phenylglycinol-derived oxazaborolidine across all ketone classes is limited; process validation therefore relies on substrate-specific enantiomeric excess by chiral HPLC, active hydride titration, and batch yield rather than universal kinetic models.

    When N-Cbz-D-Phenylglycinol Replaces Free Phenylglycinol in Aziridine Synthesis

    In this route the N-protected amino alcohol is activated at the primary hydroxyl with p-toluenesulfonyl chloride and then treated with aqueous sodium hydroxide to form N-Cbz-2-phenylaziridine. A 500 L glass-lined reactor with retreat-curve agitation is charged with N-Cbz-D-Phenylglycinol (1.00 mol), tetrahydrofuran/water (2:1 v/v), and p-toluenesulfonyl chloride (1.20 mol) at 05 °C; aqueous sodium hydroxide (2.5 mol) is added over 35 h while maintaining pH 1011. After 812 h aging, the aziridine is extracted into isopropyl acetate and crystallized from isopropanol/water. Temperature during ring-opening with primary amines must remain below 40 °C to preserve stereochemical integrity at the benzylic position. The terminal finished product type comprises N-Cbz-2-phenylaziridine and ring-opened enantiopure 1,2-diamino derivatives used as chiral ligand backbones and in selected antiviral candidate fragments. Compliance is controlled under ICH Q7 when the derivatives enter registered intermediate supply, with residual solvent limits per ICH Q3C and site use registered under REACH Regulation EC 1907/2006. Water-wet aziridine stock is not permitted because aziridine opening occurs at moisture levels above 0.5% w/w; vacuum drying at 35 °C and 20 mbar is therefore applied before packaging under nitrogen.

    Typically, N-Cbz-D-Phenylglycinol is converted through O-acylation or Mitsunobu substitution during early-stage structure-activity relationship preparation in medicinal chemistry kilo-labs. O-acylation follows 1.0 mol N-Cbz-D-Phenylglycinol, 1.11.3 mol acyl chloride, and 1.5 mol triethylamine in dichloromethane at 05 °C. Where a free amino group is required, the Cbz group is removed in a preceding hydrogenolysis step and the resulting D-phenylglycinol is subjected to reductive amination with 1.3 mol ketone or aldehyde and 1.5 mol sodium triacetoxyborohydride per 1.0 mol amino alcohol in tetrahydrofuran/1,2-dichloroethane at 020 °C in a 100 L jacketed reactor. Extractive workup against aqueous bicarbonate, silica gel filtration, and vacuum drying at 35 °C and 20 mbar yield the intermediate. The terminal finished product type is non-commercial chiral amino alcohols that act as enabling intermediates for peptide-mimetic and neurological candidate libraries. Compliance for kilo-lab batches entering investigational toxicology uses ICH Q3A and ICH Q3B for impurity qualification, ICH Q3C for residual dichloromethane, and ICH Q7 after candidate selection. Published data for scale-up of this specific substrate in continuous flow is limited; batch mode remains the default because impurity profiles require offline monitoring.

    Free Quote

    Competitive CBZ-D-Phenylglycinol prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    CBZ-D-Phenylglycinol (N-[(benzyloxy)carbonyl]-D-phenylglycinol, CAS 100237-64-2) is supplied as a white to off-white crystalline powder with molecular formula C16H17NO3 and nominal molecular weight 271.31 g/mol. The product belongs to the chiral 1,2-amino alcohol class in which the primary amine is masked as a benzyl carbamate and the stereocentre retains the D configuration. The product designation distinguishes it from Cbz-L-Phenylglycinol, Boc-D-Phenylglycinol, and Fmoc-D-Phenylglycinol, which are separate catalog items and are not interchangeable in stereoselective downstream chemistry. The material functions as a protected amino alcohol intermediate for oxazaborolidine catalyst synthesis, enantiopure 2-oxazolidinone formation, and peptide alcohol chain-end modification. The D-configuration is critical because it controls the absolute stereochemical outcome of asymmetric reductions conducted with the derived catalyst.

    Control Specification and Release Limits

    The release specification for reagent-grade CBZ-D-Phenylglycinol is based on chromatographic purity, enantiomeric purity, water content, and residue-on-ignition limits. The following limits represent a control specification for bulk fine-chemical use; each shipment should be verified against the supplier certificate of analysis.

    Parameter Method Release limit
    Appearance Visual inspection White to off-white crystalline powder
    Identification by infrared absorption USP <197> Matches reference spectrum
    Chemical purity HPLC area normalization, USP <621> ≥99.0%
    Enantiomeric purity Chiral HPLC on amylose-based chiral stationary phase ≥99.0% ee
    Water content Karl Fischer titration, USP <921> Method Ia ≤0.50%
    Residue on ignition USP <281> ≤0.10%
    Residual solvents GC-HS, USP <467> with ICH Q3C limits ≤0.50% total Class 3 solvents

    Chemical purity is determined on a reversed-phase C18 column using a trifluoroacetic acid/acetonitrile gradient with UV detection at 210 nm. Enantiomeric purity is assessed on an amylose tris(3,5-dimethylphenylcarbamate) chiral stationary phase with n-hexane/isopropanol mobile phase and UV detection at 254 nm. The chiral HPLC method is selected because the D and L enantiomers can co-elute under achiral reversed-phase conditions. Retention order must be confirmed with a racemic reference standard before batch release.

    Sealed storage under nitrogen at 2–8 °C preserves enantiomeric purity. At relative humidity above 60%, water uptake can exceed the 0.50% Karl Fischer limit within 6 h when the container is left open. The product is incompatible with strong acid chlorides, oxidising agents, and hydrogenation catalyst dust. Contact with palladium-on-carbon in the dry state can initiate benzyl carbamate cleavage and should be avoided during sampling and dispensing.

    What Limits Optical Purity During Hydrogenolytic Scale-Up?

    What limits optical purity during hydrogenolytic scale-up is not the Cbz cleavage itself but the stability window of the transient free amino alcohol. In a representative pilot-scale protocol, a 50 L Hastelloy C-22 stirred autoclave charged with 10 wt% Pd/C and ethanol is operated at 0.3–0.5 MPa hydrogen and a jacket setpoint of 20–25 °C. Debenzylation typically reaches greater than 99 mol% conversion within 2–4 h. The process window is approximately ±5 °C around setpoint: at jacket temperatures above 30–35 °C, the deprotected amino alcohol undergoes epimerisation via a Schiff-base intermediate, and enantiomeric excess falls below 99.0%. If agitation is insufficient to maintain catalyst suspension, local hot spots form and residual starting material remains, producing an impurity that may not be resolved under achiral HPLC conditions.

    Gas-liquid mass transfer is a further boundary condition in multi-kilogram hydrogenation. Reactors using hollow-shaft gas introduction and dual Rushton turbines are preferred because hydrogen starvation at the catalyst surface extends reaction time and increases racemisation. Hydrogen pressure below 0.3 MPa can double debenzylation time in the same equipment. Hydrogen pressure above 0.5 MPa increases the risk of aromatic ring hydrogenation on freshly reduced Pd/C. The quench step after catalyst filtration uses aqueous citric acid; if the quench temperature exceeds 25 °C, partial carbamate migration can occur. Published data for this specific configuration is limited, so batch-specific development work is required when transferring from glassware to production autoclaves.

    CBZ-D-Phenylglycinol is employed as the amino alcohol component in oxazaborolidine-mediated asymmetric ketone reduction. The compound is condensed with trimethylboroxine or borane–tetrahydrofuran to form the chiral oxazaborolidine catalyst. Typical catalyst loadings are 5–10 mol% relative to prochiral ketone, with reduction performed using borane–dimethyl sulfide at -10 °C to 25 °C. Water content above 0.50% consumes borane reagent and depresses enantiomeric excess below process target. Vacuum drying at 40 °C and 1–5 kPa for 12 h returns the material to Karl Fischer compliance. The Cbz group remains intact during catalyst formation and may later be removed by hydrogenolysis if the free amino alcohol is required.

    When Cbz-D-Phenylglycinol Replaces Boc-D-Phenylglycinol in Chiral Auxiliary Synthesis

    The substitution is not neutral because the protecting groups respond to different deprotection chemistries. Cbz protection is stable to the acidic conditions used for Boc removal, whereas Boc protection is stable under neutral hydrogenation. In a synthetic sequence where a tert-butyl carbamate must be removed in the presence of a Cbz group, CBZ-D-Phenylglycinol supplies the acid-stable partner. Conversely, when hydrogenation-sensitive functionalities are present, Boc-D-Phenylglycinol is preferred because the Cbz group would be lost during palladium-mediated steps.

    Parameter CBZ-D-Phenylglycinol Boc-D-Phenylglycinol Cbz-L-Phenylglycinol
    N-protecting group Benzyl carbamate tert-Butyl carbamate Benzyl carbamate
    Stereochemical configuration D-(R) D-(R) L-(S)
    Primary deprotection condition Catalytic hydrogenolysis over Pd/C, 0.3–0.5 MPa H₂ Acidolysis with 4 M HCl in dioxane or trifluoroacetic acid Catalytic hydrogenolysis over Pd/C, 0.3–0.5 MPa H₂
    Orthogonality Stable to acidic Boc removal; cleaved by hydrogenation Stable to hydrogenation; cleaved by acid Stereochemical mirror of D-series
    Principal release impurity D-phenylglycinol from Cbz loss D-phenylglycinol from Boc loss Cbz-D-phenylglycinol as enantiomeric contaminant
    Long-term storage temperature 2–8 °C -20 °C recommended 2–8 °C

    The D-enantiomer of the Cbz amino alcohol yields the opposite stereoinduction to the L-enantiomer in oxazaborolidine reductions. Enantiomeric impurity above 0.5% shifts the product ee in a direction determined by the retention order on the chiral stationary phase. CBZ-D-Phenylglycinol is also distinct from unprotected D-phenylglycinol because the free amino group in the unprotected material forms Lewis acid-base complexes prematurely with borane reagents, leading to uncontrolled exotherms during catalyst preparation. The Cbz-protected form avoids that incompatibility while retaining the 1,2-amino alcohol geometry required for oxazaborolidine formation.

    Controlling Residual Solvents in Recrystallised Bulk Lots

    Recrystallisation from ethyl acetate/heptane yields a granular solid with improved filtration rates in a 200 L glass-lined agitated filter-dryer. Terminal drying at 35–40 °C and 1–5 kPa for 12–18 h reduces residual ethyl acetate and heptane to below the 0.50% total Class 3 release limit. Methylene chloride, a Class 2 solvent, is controlled to below 600 ppm by USP <467> gas chromatography-headspace. Lots that fail residual solvent specification are re-dried rather than reprocessed, but repeated drying cycles beyond 24 h can increase esterified by-product formation through carbamate alcohol condensation.

    Residual solvent analysis uses a headspace autosampler with vial equilibration at 80 °C for 30 min. The GC system is equipped with a split injector and flame ionisation detection. Method transfer between GC instruments requires confirmation of retention time, injection liner inertness, and headspace pressure settings. If the product is drummed before the solvent content is confirmed, residual heptane can plasticise low-density polyethylene liner film and create a visible film on the solid surface. This does not alter chemical purity but can change the appearance and should be avoided by terminal sampling before packaging.

    Batch-to-batch variance in enantiomeric impurity is best controlled by chiral HPLC on an amylose tris(3,5-dimethylphenylcarbamate) column maintained at 25 °C, with n-hexane/isopropanol mobile phase and UV detection at 254 nm. In production campaigns, the main enantiomeric contaminant is the L-enantiomer arising from incomplete resolution of the starting phenylglycinol; the limit is set at ≤0.5% area. The material should not be combined with amine-reactive additives during storage, supplied as a masterbatch with borane sources, or exposed to hydrogenation catalyst dust in shared dispensing rooms.

    Top